Specialties

With the introduction of this glucagon-like peptide-1 receptor agonist (GLP-1 RA), efpeglenatide, could we see new cardiovascular and renal benefits for patients with type 2 diabetes?

Major electrocardiogram abnormalities have been found in patients with type 2 diabetes. 

How does basal insulin compare to other diabetes medications in its impact on cholesterol and triglycerides?

Genetic risk scores can help provide insight into the problem of increasing youth-onset type 2 diabetes rates.

American Diabetes Association mini-symposium presented by Biykem Bozkurt, MD, Ph.D., FHFSA, FACC, FAHA, FESC. 

A study was conducted to assess if HbA1c variability impacts the incidence of diabetic complications, all-cause and cardiovascular mortality. 

Older adults may be at risk of adverse events such as hypoglycemia when overtreated with certain medications. 

After starting SGLT-2i, is the discontinuation of therapy necessary if there is an immediate decline in estimated Glomerular Filtration Rate (eGFR) in patients?

A cohort study evaluated the relationship between the severity of newly diagnosed diabetic retinopathy in adult patients and the incidence of progression to sustained blindness. 

Lowering saturated fats in the diet for Familial Hypercholesterolemia is not supported by randomized controlled trials.